0 181

Cited 12 times in

A metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study

Authors
 Yeseung Lee  ;  a Adnan Khan  ;  Seri Hong  ;  Sun Ha Jee  ;  Youngja H. Park 
Citation
 MOLECULAR BIOSYSTEMS , Vol.13(6) : 1109-1120, 2017 
Journal Title
 MOLECULAR BIOSYSTEMS 
ISSN
 1742-206X 
Issue Date
2017
MeSH
Biomarkers/blood ; Biomarkers/metabolism ; Discriminant Analysis ; Female ; Humans ; Lysine/blood ; Lysine/metabolism ; Male ; Metabolomics ; Multivariate Analysis ; Retrospective Studies ; Stroke/blood ; Tandem Mass Spectrometry
Abstract
Identifying changes in serum metabolites during cerebral ischemia is an important approach for early diagnosis of thrombotic stroke. Herein, we highlight novel biomarkers for early diagnosis of patients at high risk of thrombotic stroke using high resolution metabolomics (HRM). In this retrospective cohort study, serum samples obtained from patients at risk of thrombotic stroke (n  =  62) and non-risk individuals (n  =  348) were tested using HRM, coupled with LC-MS/MS, to discriminate between metabolic profiles of control and stroke risk patients. Multivariate analysis and orthogonal partial least square-discriminant analysis (OPLS-DA) were performed to determine the top 5% metabolites within 95% group identities, followed by filtering with p-value <0.05 and annotating significant metabolites using a Metlin database. Mapping identified features from Kyoto Encyclopedia of Genes and Genomes (KEGG) and Mummichog resulted in 341 significant features based on OPLS-DA with p-value <0.05. Among these 341 features, nine discriminated the thrombotic stroke risk group from the control group: low levels of N6-acetyl-l-lysine, 5-aminopentanoate, cadaverine, 2-oxoglutarate, nicotinamide, l-valine, S-(2-methylpropionyl)-dihydrolipoamide-E and ubiquinone, and elevated levels of homocysteine sulfinic acid. Further analysis showed that these metabolite biomarkers are specifically related to stroke occurrence, and unrelated to other factors such as diabetes or smoking. Lower levels of lysine catabolites in thrombotic stroke risk patients, as compared to the control, supports targeting these compounds as novel biomarkers for early and non-invasive detection of a thrombotic stroke.
Full Text
http://pubs.rsc.org/en/content/articlepdf/2017/mb/c6mb00732e
DOI
10.1039/c6mb00732e
Appears in Collections:
4. Graduate School of Public Health (보건대학원) > Graduate School of Public Health (보건대학원) > 1. Journal Papers
Yonsei Authors
Jee, Sun Ha(지선하) ORCID logo https://orcid.org/0000-0001-9519-3068
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160582
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse